Sinobiopharma has acquired rights to the following patents – Synthesis of amantadine hydrochloride, method for preparation of 17-acylsinomenine derivatives, preparation of 17-sulfonylsinomenine, preparation of N-substituted sinomenine, method for preparation of Sinomenine compound having dextro-rotary C ring-deficient morphinan skeleton, synthesis of Eplerenone from 11 -hydroxycanrenone and method for resolving tetrahydroisoquinoline racemate.
The patents are expected to significantly enhance Sinobiopharma’s ability to execute on its mission of bringing safe, low-cost, high-efficacy biopharmaceuticals to market.
Sinobiopharma will be applying these patents as well as using its own innovative applications of them in new drug development.